Ignite Creation Date:
2025-12-25 @ 2:21 AM
Ignite Modification Date:
2026-03-02 @ 4:22 PM
Study NCT ID:
NCT03323034
Status:
COMPLETED
Last Update Posted:
2024-10-22
First Post:
2017-10-11
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Pevonedistat, Irinotecan, and Temozolomide in Treating Patients With Recurrent or Refractory Solid Tumors or Lymphoma
Sponsor:
Children's Oncology Group
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Recurrent Lymphoma | View |
| None | Recurrent Malignant Solid Neoplasm | View |
| None | Recurrent Primary Central Nervous System Neoplasm | View |
| None | Refractory Lymphoma | View |
| None | Refractory Malignant Solid Neoplasm | View |
| None | Refractory Primary Central Nervous System Neoplasm | View |
Keywords: